Trends in net survival from 15 cancers in six European Latin countries

Emanuele Crocetti, Nadine Bossard, Zoe Uhry, Laurent Roche, Silvia Rossi, Riccardo Capocaccia, Jean Faivre, GRELL EUROCARE-5 Working Group, Gemma Gatta, Milena Sant, Hade Amash, Lucia Mangone

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries.
Original languageEnglish
Pages (from-to)S3-S8
JournalEuropean Journal of Cancer Prevention
Volume26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study
DOIs
Publication statusPublished - Jan 2017

Fingerprint

Neoplasms
Italy
Death Certificates
Portugal
Lost to Follow-Up
Belgium
Switzerland
Spain
France
Mortality
Survival Analysis
Registries
Databases
Population
Data Accuracy

Keywords

  • Journal Article

Cite this

Crocetti, E., Bossard, N., Uhry, Z., Roche, L., Rossi, S., Capocaccia, R., ... Mangone, L. (2017). Trends in net survival from 15 cancers in six European Latin countries. European Journal of Cancer Prevention, 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, S3-S8. https://doi.org/10.1097/CEJ.0000000000000300

Trends in net survival from 15 cancers in six European Latin countries. / Crocetti, Emanuele; Bossard, Nadine; Uhry, Zoe; Roche, Laurent; Rossi, Silvia; Capocaccia, Riccardo; Faivre, Jean; Group, GRELL EUROCARE-5 Working; Gatta, Gemma; Sant, Milena; Amash, Hade; Mangone, Lucia.

In: European Journal of Cancer Prevention, Vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, 01.2017, p. S3-S8.

Research output: Contribution to journalArticle

Crocetti, E, Bossard, N, Uhry, Z, Roche, L, Rossi, S, Capocaccia, R, Faivre, J, Group, GRELLEUROCAREW, Gatta, G, Sant, M, Amash, H & Mangone, L 2017, 'Trends in net survival from 15 cancers in six European Latin countries', European Journal of Cancer Prevention, vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S3-S8. https://doi.org/10.1097/CEJ.0000000000000300
Crocetti E, Bossard N, Uhry Z, Roche L, Rossi S, Capocaccia R et al. Trends in net survival from 15 cancers in six European Latin countries. European Journal of Cancer Prevention. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S3-S8. https://doi.org/10.1097/CEJ.0000000000000300
Crocetti, Emanuele ; Bossard, Nadine ; Uhry, Zoe ; Roche, Laurent ; Rossi, Silvia ; Capocaccia, Riccardo ; Faivre, Jean ; Group, GRELL EUROCARE-5 Working ; Gatta, Gemma ; Sant, Milena ; Amash, Hade ; Mangone, Lucia. / Trends in net survival from 15 cancers in six European Latin countries. In: European Journal of Cancer Prevention. 2017 ; Vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study. pp. S3-S8.
@article{d03b8984f6bd440eb5edc8735c47240b,
title = "Trends in net survival from 15 cancers in six European Latin countries",
abstract = "The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries.",
keywords = "Journal Article",
author = "Emanuele Crocetti and Nadine Bossard and Zoe Uhry and Laurent Roche and Silvia Rossi and Riccardo Capocaccia and Jean Faivre and Group, {GRELL EUROCARE-5 Working} and Gemma Gatta and Milena Sant and Hade Amash and Lucia Mangone",
year = "2017",
month = "1",
doi = "10.1097/CEJ.0000000000000300",
language = "English",
volume = "26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study",
pages = "S3--S8",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Trends in net survival from 15 cancers in six European Latin countries

AU - Crocetti, Emanuele

AU - Bossard, Nadine

AU - Uhry, Zoe

AU - Roche, Laurent

AU - Rossi, Silvia

AU - Capocaccia, Riccardo

AU - Faivre, Jean

AU - Group, GRELL EUROCARE-5 Working

AU - Gatta, Gemma

AU - Sant, Milena

AU - Amash, Hade

AU - Mangone, Lucia

PY - 2017/1

Y1 - 2017/1

N2 - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries.

AB - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries.

KW - Journal Article

U2 - 10.1097/CEJ.0000000000000300

DO - 10.1097/CEJ.0000000000000300

M3 - Article

VL - 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study

SP - S3-S8

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

ER -